Watch for Acid-Reducer Interactions With New Hep C Med Harvoni

December 2014

Please see new warnings concerning the use of amiodarone with Harvoni or Sovaldi

You'll see two new ORAL hepatitis C regimens...Harvoni (har-VOE-nee) and Olysio (simeprevir) PLUS Sovaldi (sofosbuvir).

These new regimens are changing hep C therapy again...because they eliminate the need for ribavirin and interferon for most patients.

Harvoni is a new once-daily tablet that combines Sovaldi with a new antiviral, ledipasvir.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Opioids Try an NSAID Instead of Opioids for Chronic Musculoskeletal Pain
Asthma Use the "Rule of Two" to Help Improve Asthma Care
Women's Health Explain IUDs are Covered Under the Affordable Care Act
Diabetes Consider GLP-1 Agonists...Including New Trulicity...as Metformin Add-Ons
Diabetes Remind Patients to Gently Mix "Cloudy" Insulins...Even in Pens
Corticosteroids Advise Patients to Report Psychiatric Effects With Steroids
Hepatitis C Watch for Acid-Reducer Interactions With New Hep C Med Harvoni
Influenza Save Flu Antivirals for Severely Ill or High-Risk Patients
Wound Care Don't Assume Expensive Wound Dressings Work Better
Antiemetics Reassure Chemo Patients That Oral Antiemetics Work Well
Antithrombotics Emphasize Daily Adherence With the New Oral Anticoagulants After Cardioversion
Infection Control Use Soap and Water After C. Difficile or Norovirus Exposure